These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22768738)

  • 21. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
    Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
    Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches in the management of heart failure.
    Mason DT
    Adv Myocardiol; 1980; 1():453-68. PubMed ID: 6994186
    [No Abstract]   [Full Text] [Related]  

  • 24. [Congenital heart disease and acquired valvular lesions in pregnancy].
    Horstkotte D; Fassbender D; Piper C
    Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic modulation in heart failure: high time for a definitive clinical trial.
    Ashrafian H; Neubauer S
    Heart; 2011 Feb; 97(4):267-8. PubMed ID: 21258118
    [No Abstract]   [Full Text] [Related]  

  • 26. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perhexiline.
    Ashrafian H; Horowitz JD; Frenneaux MP
    Cardiovasc Drug Rev; 2007; 25(1):76-97. PubMed ID: 17445089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
    Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
    Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilators in the treatment of heart failure.
    Mehta J
    JAMA; 1977 Dec; 238(23):2534-6. PubMed ID: 578895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure.
    Natori S; Hasebe N; Jin YT; Matsusaka T; Ido A; Matsuhashi H; Ihara T; Kikuchi K
    Am J Respir Crit Care Med; 2003 Mar; 167(6):895-901. PubMed ID: 12519739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasodilator agents in chronic heart failure.
    Chatterjee K
    Dan Med Bull; 1983 Apr; 30 Suppl 1():1-9. PubMed ID: 6345096
    [No Abstract]   [Full Text] [Related]  

  • 35. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
    Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
    Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Congestive heart failure in adults. Etiology, physiopathology, diagnosis, course, treatment].
    Lopes ME; Hittinger L
    Rev Prat; 1999 Apr; 49(7):765-76. PubMed ID: 10337224
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac P2X(4) receptors: targets in ischemia and heart failure?
    Yang R; Liang BT
    Circ Res; 2012 Aug; 111(4):397-401. PubMed ID: 22859669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of aortic impedance on left ventricular function in aortic stenosis.
    Khalilullah M; Sethi KK
    Indian Heart J; 1982; 34(3):125-7. PubMed ID: 7129488
    [No Abstract]   [Full Text] [Related]  

  • 39. Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?
    Chirkov YY; Horowitz JD
    Pharmacol Ther; 2007 Nov; 116(2):287-305. PubMed ID: 17765975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of systolic and diastolic disorders in the development of heart failure].
    Belenkov IuN
    Ter Arkh; 1994; 66(9):3-7. PubMed ID: 7992208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.